Summary Neovasc Inc. (Neovasc) is a medical device company that develops, manufactures and sells products for cardiovascular disease. The company offers products such as tiara, reducer and tissue products. Its Tiara is a novel transcatheter device that is designed for treating mitral regurgitation (MR), a condition that is often severe and can lead to heart failure and death. Neovasc biological tissue products are used as components in third-party medical products that include transcatheter heart valves. The company's reducer is used for the treating refractory angina. Neovasc is headquartered in Richmond, British Columbia, Canada. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Neovasc Inc. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons To Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 Neovasc Inc. Company Snapshot 6 Neovasc Inc. Company Overview 6 Neovasc Inc. Pipeline Products and Clinical Trials Overview 7 Neovasc Inc.- Pipeline Analysis Overview 9 Key Facts 9 Neovasc Inc. - Major Products and Services 10 Neovasc Inc. Pipeline Products by Development Stage 11 Neovasc Inc. Clinical Trials by Trial Status 13 Neovasc Inc. Pipeline Products Overview 15 Aorto-Ostial Stent Delivery System 15 Aorto-Ostial Stent Delivery System Product Overview 15 Coronary Bifurcation Stent Delivery System 16 Coronary Bifurcation Stent Delivery System Product Overview 16 Neovasc Reducer 17 Neovasc Reducer Product Overview 17 Neovasc Reducer Clinical Trial 18 Ostial Balloon 19 Ostial Balloon Product Overview 19 Ostial Flare 20 Ostial Flare Product Overview 20 Tiara Transcatheter Mitral Valve 21 Tiara Transcatheter Mitral Valve Product Overview 21 Tiara Transcatheter Mitral Valve Clinical Trial 22 Neovasc Inc. - Key Competitors 23 Neovasc Inc. - Key Employees 24 Neovasc Inc. - Locations And Subsidiaries 25 Head Office 25 Other Locations & Subsidiaries 25 Recent Developments 26 Neovasc Inc., Recent Developments 26 May 19, 2016: Neovasc Announces Jury Verdict in Litigation Brought by CardiAQ 26 Apr 29, 2016: Neovasc Reports First Quarter Results for 2016 26 Mar 29, 2016: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2015 28 Jan 11, 2016: Neovasc Receives FDA Approval to add 40mm Valve Size to the TIARA-I Clinical Trial 31 Nov 09, 2015: Neovasc Reports Results for the Third Quarter of 2015 31 Oct 16, 2015: Neovasc Tiara Featured in Live Case Session at TCT 2015 Scientific Symposium 34 Aug 06, 2015: Neovasc Reports Results for the Second Quarter of 2015 34 May 12, 2015: Neovasc Reports Results for the First Quarter of 2015 37 Mar 30, 2015: Neovasc Announces Results for the Fourth Quarter and Full Year Ended 2014 39 Mar 19, 2015: Neovasc Launches Reducer in Select European Countries 42 Appendix 43 About GlobalData 43 Contact Us 43 Disclaimer 43
List of Tables
Neovasc Inc. Pipeline Products and Clinical Trials Overview 7 Neovasc Inc. Pipeline Products by Equipment Type 7 Neovasc Inc. Pipeline Products by Indication 8 Neovasc Inc. Clinical Trials by Trial Status 8 Neovasc Inc., Key Facts 9 Neovasc Inc., Major Products and Services 10 Neovasc Inc. Number of Pipeline Products by Development Stage 11 Neovasc Inc. Pipeline Products Summary by Development Stage 12 Neovasc Inc. Clinical Trials by Trial Status 13 Neovasc Inc. Clinical Trials Summary 14 Aorto-Ostial Stent Delivery System - Product Status 15 Aorto-Ostial Stent Delivery System - Product Description 15 Coronary Bifurcation Stent Delivery System - Product Status 16 Coronary Bifurcation Stent Delivery System - Product Description 16 Neovasc Reducer - Product Status 17 Neovasc Reducer - Product Description 17 Neovasc Reducer - REDUCER-I: An Observational Study of the Neovasc Reducer System 18 Neovasc Reducer - Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients with Angina Class 3-4 Who Are Not Candidates for Revascularization 18 Ostial Balloon - Product Status 19 Ostial Balloon - Product Description 19 Ostial Flare - Product Status 20 Ostial Flare - Product Description 20 Tiara Transcatheter Mitral Valve - Product Status 21 Tiara Transcatheter Mitral Valve - Product Description 21 Tiara Transcatheter Mitral Valve - Early Feasibility Study of the Neovasc Tiara Mitral Transcatheter Heart Valve with the Tiara Transapical Delivery System 22 Neovasc Inc., Key Employees 24 Neovasc Inc., Subsidiaries 25
List of Figures
Neovasc Inc. Pipeline Products by Equipment Type 8 Neovasc Inc. Pipeline Products by Development Stage 11 Neovasc Inc. Clinical Trials by Trial Status 13
Europe industrial air filtration market size is projected to reach USD 1,690.8 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing implementation in various industries such as metal, cement and food & beverages among otRead More...
Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the markeRead More...
Global Bio polyethylene terephthalate (PET) market size is likely to be valued at USD 12.6 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing preference of biopolymers in numerous applications coupled with favorable goverRead More...
Global intelligent transportation system (ITS) market is estimated to attain USD 38.68 billion by 2020, as per a new research report by Radiant Insights, Inc. Cost effectiveness along with escalating need for road safety is likely to boost global demRead More...
Global automotive ECU market is projected to be valued at USD 45.98 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising use in infotainment systems coupled with high deployment in electric vehicles applications is expectedRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.